Basic Information
RNALocate ID: | RLID:11002833 |
RNA Symbol: | hsa-miR-451a |
Localization: | Extracellular vesicle |
RNA Information
RNA Name: | hsa-miR-451 |
RNA ID: | miRBase:MIMAT0001631 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 22849433 |
Tissue/Cell Line: | HEK-293T cells |
Method: | Next-generation RNA sequencing |
Description: | The total numbers of reads >15 bp matching each miRNA were calculated. These values were then normalized to number of reads per million mapped (RPMM) in each library, to enable direct comparison of expression levels. As a measure of the relative levels of expression of individual miRNAs in cells and EVs, the log (base two) of the ratio of the read number in EVs over that in cells was calculated (log2 (EV/cell)). The miRNA expression data for cells and EVs is presented in Additional file 1: Table S1. Data are collected from Table S1. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11002818 | Exosome | Primary T lymphocytes | 24356509 |
RLID:11002819 | Exosome | Plasma | 29130611 |
RLID:11002820 | Exosome | Peripheral blood|Portal vein blood | 30561106 |
RLID:11002821 | Exosome | Serum | 18589210 |
RLID:11002822 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11002823 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11002824 | Exosome | B cell line (Raji)|Jurkat-derived T cell line (J77cl20) | 21505438 |
RLID:11002825 | Exosome | Renal cancer cells | 21670082 |
RLID:11002826 | Exosome | HCC cell line (Hep3B|HepG2|PLC/PRF/5) | 21721029 |
RLID:11002827 | Exosome | Brain tissue | 23382797 |
RLID:11002828 | Exosome | Plasma | 23663360 |
RLID:11002829 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11002830 | Exosome | Plasma | 24130905 |
RLID:11002831 | Exosome | B cell lymphoma cell lines|EBV-transformed lymphoblastoid B cells | 25242326 |
RLID:11002832 | Extracellular Vesicle | Liposarcoma cell lines (Lipo224B|Lipo246|Lipo863|LPS141)|Preadipocytes | 28588009 |
RLID:11002834 | Extracellular vesicle | Colon cancer cell line (LIM1863) | 25330373 |
RLID:11002835 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
RLID:11002836 | Microvesicle | Liver resident stem cells|Mesenchymal stem cells | 20668554 |
RLID:11002837 | Microvesicle | Plasma | 23077538 |
RLID-D:11000144 | Exosome | Blood|B lymphoblastoid cells|Endothelial cells|Lymphoma tissue|Mast cells | |
RLID-D:11000461 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-mir-451a | Pterygium | MNDR-E-MI-51116 |
MNDR | hsa-mir-451a | Adult T cell leukemia | MNDR-E-MI-51117 |
MNDR | hsa-miR-451a | Large cell neuroendocrine cancer | MNDR-E-MI-51118 |
MNDR | hsa-miR-451a | Follicular lymphoma | MNDR-E-MI-51119 |
MNDR | hsa-miR-451a | Medulloblastoma | MNDR-E-MI-51120 |
MNDR | hsa-miR-451a | High-grade serous ovarian carcinoma | MNDR-E-MI-51121 |
MNDR | hsa-miR-451a | Ovarian clear cell carcinoma | MNDR-E-MI-51122 |
MNDR | hsa-miR-451a | Uterine corpus endometrial carcinoma | MNDR-E-MI-51123 |
MNDR | hsa-miR-451a | Lymphoma | MNDR-E-MI-51124 |
MNDR | hsa-miR-451a | Estrogen-receptor positive breast cancer | MNDR-E-MI-51125 |
MNDR | hsa-miR-451a | Estrogen-receptor negative breast cancer | MNDR-E-MI-51126 |
MNDR | hsa-miR-451a | Progesterone-receptor positive breast cancer | MNDR-E-MI-51127 |
MNDR | hsa-miR-451a | Progesterone-receptor negative breast cancer | MNDR-E-MI-51128 |
MNDR | hsa-miR-451a | Her2-receptor positive breast cancer | MNDR-E-MI-51129 |
MNDR | hsa-miR-451a | Breast cancer luminal | MNDR-E-MI-51130 |
MNDR | hsa-miR-451a | Anencephaly | MNDR-E-MI-51131 |
MNDR | hsa-miR-451a | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-51132 |
MNDR | hsa-mir-451a | Colorectal carcinoma | MNDR-E-MI-51133 |
MNDR | hsa-miR-451a | Fatty liver non-alcoholic | MNDR-E-MI-51134 |
MNDR | hsa-mir-451a | Fatty liver non-alcoholic | MNDR-E-MI-51135 |
MNDR | hsa-mir-451a | Acth-independent macronodular adrenal hyperplasia; aimah | MNDR-E-MI-51136 |
MNDR | hsa-miR-451a | Prostate cancer | MNDR-E-MI-51137 |
MNDR | hsa-mir-451a | Early-stage gastric carcinoma | MNDR-E-MI-51138 |
MNDR | hsa-miR-451a | Gastric cancer | MNDR-E-MI-51139 |
MNDR | hsa-miR-451a | Alzheimer disease | MNDR-E-MI-51140 |
MNDR | hsa-miR-451a | Sickle cell anemia | MNDR-E-MI-51141 |
MNDR | hsa-mir-451a | Sickle cell diseases | MNDR-E-MI-51142 |
MNDR | hsa-miR-451a | Intracranial aneurysm | MNDR-E-MI-51143 |
MNDR | hsa-mir-451a | Bladder cancer | MNDR-E-MI-51144 |
MNDR | hsa-miR-451a | Esophageal carcinoma | MNDR-E-MI-51145 |
MNDR | hsa-mir-451a | Esophageal carcinoma | MNDR-E-MI-51146 |
MNDR | hsa-miR-451a | Sarcoma | MNDR-E-MI-51147 |
MNDR | hsa-miR-451a | Dysautonomia familial | MNDR-E-MI-51148 |
MNDR | hsa-miR-451a | Seizures | MNDR-E-MI-51149 |
MNDR | hsa-miR-451a | Head and neck cancer | MNDR-E-MI-51150 |
MNDR | hsa-miR-451a | Hypertrophic cardiomyopathy | MNDR-E-MI-51151 |
MNDR | hsa-miR-451a | Primary biliary cirrhosis | MNDR-E-MI-51152 |
MNDR | hsa-miR-451a | Malaria | MNDR-E-MI-51153 |
MNDR | hsa-mir-451a | Malaria | MNDR-E-MI-51154 |
MNDR | hsa-miR-451a | Leukemia | MNDR-E-MI-51155 |
MNDR | hsa-mir-451a | Leiomyoma | MNDR-E-MI-51156 |
MNDR | hsa-miR-451a | Huntington disease | MNDR-E-MI-51157 |
MNDR | hsa-miR-451a | Chorea | MNDR-E-MI-51158 |
MNDR | hsa-miR-451a | Cardiovascular disease | MNDR-E-MI-51159 |
MNDR | hsa-mir-451a | Dilated cardiomyopathy | MNDR-E-MI-51160 |
MNDR | hsa-miR-451a | Moyamoya disease | MNDR-E-MI-51161 |
MNDR | hsa-miR-451a | Brain cancer | MNDR-E-MI-51162 |
MNDR | hsa-miR-451a | Uterine fibroid | MNDR-E-MI-51163 |
MNDR | hsa-mir-451a | Lung cancer | MNDR-E-MI-51164 |
MNDR | hsa-miR-451a | Lung cancer | MNDR-E-MI-51165 |
MNDR | hsa-miR-451a | Down syndrome | MNDR-E-MI-51166 |
MNDR | hsa-miR-451a | Parkinson disease | MNDR-E-MI-51167 |
MNDR | hsa-miR-451a | Major depressive disorder | MNDR-E-MI-51168 |
MNDR | hsa-miR-451a | Basal-like breast cancer | MNDR-E-MI-51169 |
MNDR | hsa-mir-451a | Breast cancer | MNDR-E-MI-51170 |
MNDR | hsa-mir-451a | Neoplasms | MNDR-E-MI-51171 |
MNDR | hsa-mir-451a | Squamous cell carcinoma | MNDR-E-MI-51172 |
MNDR | hsa-miR-451a | Thyroid cancer | MNDR-E-MI-51173 |
MNDR | hsa-miR-451a | Pituitary neoplasms | MNDR-E-MI-51174 |
MNDR | hsa-mir-451a | Pancreatic cancer | MNDR-E-MI-51175 |
MNDR | hsa-miR-451a | Pancreatic cancer | MNDR-E-MI-51176 |
MNDR | hsa-mir-451a | Supravalvar aortic stenosis | MNDR-E-MI-51177 |
MNDR | hsa-miR-451a | Rectum adenocarcinoma | MNDR-E-MI-51178 |
MNDR | hsa-miR-451a | Nephroblastoma | MNDR-E-MI-51179 |
MNDR | hsa-miR-451a | Colon cancer | MNDR-E-MI-51180 |
MNDR | hsa-mir-451a | Colon cancer | MNDR-E-MI-51181 |
MNDR | hsa-miR-451a | Ischemic attack transient | MNDR-E-MI-51182 |
MNDR | hsa-miR-451a | Colon adenocarcinoma | MNDR-E-MI-51183 |
MNDR | hsa-miR-451a | Multiple sclerosis relapsing-remitting | MNDR-E-MI-51184 |
MNDR | hsa-miR-451a | Familial ovarian cancer | MNDR-E-MI-51185 |
MNDR | hsa-mir-451a | Ovarian cancer | MNDR-E-MI-51186 |
MNDR | hsa-mir-451a | Basal cell carcinoma | MNDR-E-MI-51187 |
MNDR | hsa-miR-451a | Prostate adenocarcinoma | MNDR-E-MI-51188 |
MNDR | hsa-miR-451a | Thyroid adenomas | MNDR-E-MI-51189 |
MNDR | hsa-mir-451a | Pulmonary tuberculosis | MNDR-E-MI-51190 |
MNDR | hsa-miR-451a | Carcinoma ductal breast | MNDR-E-MI-51191 |
MNDR | hsa-miR-451a | Glioblastoma | MNDR-E-MI-51192 |
MNDR | hsa-mir-451a | Glioblastoma | MNDR-E-MI-51193 |
MNDR | hsa-mir-451a | Glioblastoma multiforme somatic | MNDR-E-MI-51194 |
MNDR | hsa-miR-451a | Glioma | MNDR-E-MI-51195 |
MNDR | hsa-mir-451a | Glioma | MNDR-E-MI-51196 |
MNDR | hsa-miR-451a | Chronic obstructive pulmonary disease | MNDR-E-MI-51197 |
MNDR | hsa-mir-451a | Gastrointestinal neoplasms | MNDR-E-MI-51198 |
MNDR | hsa-miR-451a | Amyotrophic lateral sclerosis | MNDR-E-MI-51199 |
MNDR | hsa-miR-451a | Epilepsy temporal lobe | MNDR-E-MI-51200 |
MNDR | hsa-miR-451a | Osteosarcoma | MNDR-E-MI-51201 |
MNDR | hsa-mir-451a | Osteosarcoma | MNDR-E-MI-51202 |
MNDR | hsa-miR-451a | Liposarcoma | MNDR-E-MI-51203 |
MNDR | hsa-mir-451a | Liposarcoma | MNDR-E-MI-51204 |
MNDR | hsa-miR-451a | Breast carcinoma | MNDR-E-MI-51205 |
MNDR | hsa-miR-451a | Meningioma | MNDR-E-MI-51206 |
MNDR | hsa-miR-451a | Liver cancer | MNDR-E-MI-51207 |
MNDR | hsa-mir-451a | Mucinous cystadenocarcinoma | MNDR-E-MI-51208 |
MNDR | hsa-miR-451a | Cervical adenocarcinoma | MNDR-E-MI-51209 |
MNDR | hsa-miR-451a | Gastric adenocarcinoma | MNDR-E-MI-51210 |
MNDR | hsa-miR-451a | Cervical squamous cell carcinoma | MNDR-E-MI-51211 |
MNDR | hsa-miR-451a | Pituitary adenoma | MNDR-E-MI-51212 |
MNDR | hsa-miR-451a | Lung squamous cell carcinoma | MNDR-E-MI-51213 |
MNDR | hsa-mir-451a | Carcinoma lung non-small-cell | MNDR-E-MI-51214 |
MNDR | hsa-miR-451a | Non-small cell lung cancer | MNDR-E-MI-51215 |
MNDR | hsa-miR-451a | Lung adenocarcinoma | MNDR-E-MI-51216 |
MNDR | hsa-mir-451a | Lung adenocarcinoma | MNDR-E-MI-51217 |
MNDR | hsa-miR-451a | Thyroid carcinoma | MNDR-E-MI-51218 |
MNDR | hsa-mir-451a | Papillary thyroid carcinoma | MNDR-E-MI-51219 |
MNDR | hsa-miR-451a | Ovarian carcinoma | MNDR-E-MI-51220 |
MNDR | hsa-miR-451a | Bladder urothelial carcinoma | MNDR-E-MI-51221 |
MNDR | hsa-miR-451a | Pancreatic adenocarcinoma | MNDR-E-MI-51222 |
MNDR | hsa-mir-451a | Cervical cancer | MNDR-E-MI-51223 |
MNDR | hsa-miR-451a | Myasthenia gravis autoimmune experimental | MNDR-E-MI-51224 |
MNDR | hsa-miR-451a | Carcinoma renal cell | MNDR-E-MI-51225 |
MNDR | hsa-mir-451a | Renal cell carcinoma | MNDR-E-MI-51226 |
MNDR | hsa-miR-451a | Kidney renal papillary cell carcinoma | MNDR-E-MI-51227 |
MNDR | hsa-miR-451a | Renal clear cell carcinoma | MNDR-E-MI-51228 |
MNDR | hsa-miR-451a | Large cell carcinoma | MNDR-E-MI-51229 |
MNDR | hsa-miR-451a | Biliary tract cancer | MNDR-E-MI-51230 |
MNDR | hsa-miR-451a | Intrahepatic cholangiocarcinoma | MNDR-E-MI-51231 |
MNDR | hsa-miR-451a | Cholangiocarcinoma | MNDR-E-MI-51232 |
MNDR | hsa-mir-451a | Esophageal cancer | MNDR-E-MI-51233 |
MNDR | hsa-miR-451a | Esophageal cancer | MNDR-E-MI-51234 |
MNDR | hsa-miR-451a | Liver cirrhosis | MNDR-E-MI-51235 |
MNDR | hsa-miR-451a | Prolactinoma | MNDR-E-MI-51236 |
MNDR | hsa-miR-451a | Lung small cell carcinoma | MNDR-E-MI-51237 |
MNDR | hsa-miR-451a | Head and neck squamous cell carcinoma | MNDR-E-MI-51238 |
MNDR | hsa-mir-451a | Head and neck squamous cell carcinoma | MNDR-E-MI-51239 |
MNDR | hsa-mir-451a | Myocardial infarction | MNDR-E-MI-51240 |
MNDR | hsa-miR-451a | Fibromyalgia | MNDR-E-MI-51241 |
MNDR | hsa-mir-451a | Pulmonary hypertension | MNDR-E-MI-51242 |
MNDR | hsa-miR-451a | Adenoma | MNDR-E-MI-51243 |
MNDR | hsa-miR-451a | Breast invasive carcinoma | MNDR-E-MI-51244 |
MNDR | hsa-mir-451a | Carcinoma hepatocellular | MNDR-E-MI-51245 |
MNDR | hsa-miR-451a | Early hepatocellular carcinoma | MNDR-E-MI-51246 |
MNDR | hsa-miR-451a | Embryonal cancer | MNDR-E-MI-51247 |
MNDR | hsa-miR-451a | Familiar ovarian carcinoma | MNDR-E-MI-51248 |
MNDR | hsa-mir-451a | Precursor b-cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-51249 |
MNDR | hsa-miR-451a | B-cell lymphoma | MNDR-E-MI-51250 |
MNDR | hsa-mir-451a | Rheumatoid arthritis | MNDR-E-MI-51251 |
MNDR | hsa-miR-451a | Rheumatoid arthritis | MNDR-E-MI-51252 |
MNDR | hsa-mir-451a | Hypopharyngeal cancer | MNDR-E-MI-51253 |
MNDR | hsa-mir-451a | Gastroesphageal reflux | MNDR-E-MI-51254 |
MNDR | hsa-miR-451a | Chronic myelogenous leukemia | MNDR-E-MI-51255 |
MNDR | hsa-mir-451a | Chronic myelogenous leukemia | MNDR-E-MI-51256 |
MNDR | hsa-miR-451a | Neuromyelitis optica | MNDR-E-MI-51257 |
MNDR | hsa-mir-451a | Polycythemia vera | MNDR-E-MI-51258 |
MNDR | hsa-miR-451a | Acute myelocytic leukemia | MNDR-E-MI-51259 |
MNDR | hsa-mir-451a | Acute myeloid leukemia | MNDR-E-MI-51260 |
MNDR | hsa-miR-451a | Colorectal cancer | MNDR-E-MI-51261 |
MNDR | hsa-mir-451a | Colorectal cancer | MNDR-E-MI-51262 |
MNDR | hsa-mir-451a | Carcinoma nasopharyngeal | MNDR-E-MI-51263 |
MNDR | hsa-mir-451a | Nasopharynx carcinoma | MNDR-E-MI-51264 |
MNDR | hsa-miR-451a | Tyrosinemias | MNDR-E-MI-51265 |
MNDR | hsa-miR-451a | Leukemia lymphoblastic acute | MNDR-E-MI-51266 |
MNDR | hsa-mir-451a | Diabetic nephropathies | MNDR-E-MI-51267 |
MNDR | hsa-miR-451a | Ependymoma | MNDR-E-MI-51268 |
MNDR | hsa-mir-451a | Erythropoiesis | MNDR-E-MI-51269 |
MNDR | hsa-miR-451a | Hearing loss noise-induced | MNDR-E-MI-51270 |
MNDR | hsa-miR-451a | Cardiomegaly | MNDR-E-MI-51271 |
MNDR | hsa-mir-451a | Infection | MNDR-E-MI-51272 |
MNDR | hsa-miR-451a | Nasopharyngeal cancer | MNDR-E-MI-51273 |
MNDR | hsa-mir-451a | Trophoblasts | MNDR-E-MI-51274 |
MNDR | hsa-mir-451a | Retinal neovascularization | MNDR-E-MI-51275 |
MNDR | hsa-mir-451a | Ischemic heart disease | MNDR-E-MI-51276 |
MNDR | hsa-miR-451a | Subarachnoid hemorrhage traumatic | MNDR-E-MI-51277 |
MNDR | hsa-miR-451a | Stroke lacunar | MNDR-E-MI-51278 |
MNDR | hsa-mir-451a | Non-alcoholic fatty liver disease | MNDR-E-MI-51279 |
MNDR | hsa-miR-451a | Breast cancer her3+ negative | MNDR-E-MI-51280 |
MNDR | hsa-miR-451a | High grade dysplastic nodule | MNDR-E-MI-51281 |
MNDR | hsa-mir-451a | Hypopharyngeal squamous cell carcinoma | MNDR-E-MI-51282 |
MNDR | hsa-mir-451a | Stroke susceptibility | MNDR-E-MI-51283 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCB1 | Homo sapiens | RR00022787 |
TOP